OVERVIEW

A Scientific Update of the Early Diagnosis and Management of Systemic Sclerosis Interstitial Lung Disease is organized by AcademicCME.

Program Dates: June 17, 2019 - June 16, 2020

Target Audience:
Rheumatologists, pulmonologists, primary care physicians, internists, nurses, nurse practitioners, physician assistants, and other health care providers that are involved in the management of SSc-ILD

Accreditation:
• AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.
• AcademicCME designates this enduring material for a maximum of 1.0 CNE contact hour (1.0 CNE pharmacotherapeutic contact hours). Provider number P0491.

Program Overview:
This CME/CNE program is derived from content presented at the Congress of Clinical Rheumatology 2019. The expert faculty will provide clinicians with an update on the hot topic of systemic sclerosis interstitial lung disease (SSc-ILD) as it relates to patient care in rheumatology. The expert faculty will review pathophysiology and recent treatment guidelines for accurate detection and diagnosis of SSc-ILD. New clinical trial data of SSc-ILD therapeutics will be analyzed, debating the clinical relevance in the rheumatology treatment landscape. Best practices for optimally managing patients with SSc-ILD and other comorbidities, particularly adverse events, will be highlighted. This CME/CNE activity will provide clinicians with practical information for improving care of systemic sclerosis interstitial lung disease patients.

Learning Objectives:
• Understand basic pathological progression underlying disability and death in SSc-ILD
• Recognize risk factors that predict death and disability in SSc-ILD
• Become familiar with assessment tools for screening and monitoring of SSc-ILD
• Understand the repertoire of potential treatments in SSc-ILD
• Consider important non-pharmaceutical management in SSc-ILD

Additional details will be posted as soon as information is available.